中交建(01800.HK)首季新簽合同額4,306.93億人幣 按年增4.9%
中國交通建設(01800.HK)公布,今年首季新簽合同額為4,306.93億元人民幣(下同),按年增4.9%,較去年四季度相比增64.89%,完成年度目標的30%。
當中,基建建設業務、基建設計業務、疏浚業務和其他業務分別為3,792.77億元、165.22億元、325.13億元和23.81億元。
此外,新簽基礎設施等投資類項目總投資概算為709.4億元,按照公司股比確認合同額為450.29億元,預計在設計與施工環節集團可承接的建安合同額為400.26億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.